Romualdo Luis García de Guadiana, Torrella Patricia Esteban, González Monserrat Viqueira, Sánchez Roberto Jiménez, Holgado Ana Hernando, Freire Alejandro Ortín, Acebes Sergio Rebollo, Otón María Dolores Albaladejo
Biochemistry Department, University Hospital Santa Lucía, Spain.
Biochemistry Department, University Hospital Santa Lucía, Spain.
Clin Biochem. 2014 May;47(7-8):505-8. doi: 10.1016/j.clinbiochem.2014.02.011. Epub 2014 Feb 20.
Bacteremia is indicative of severe bacterial infection with significant mortality. Its early diagnosis is extremely important for implementation of antimicrobial therapy but a diagnostic challenge. Although blood culture is the "gold standard" for diagnosis of bacteremia this method has limited usefulness for the early detection of blood-stream infection. In this study we assessed the presepsin as predictor of bacteremia in patients with systemic inflammatory response syndrome (SIRS) on admission to the Emergency Department and compare it with current available infection biomarkers.
A total of 226 patients admitted to the Emergency Department with SIRS were included. In 37 patients blood culture had a positive result (bacteremic SIRS group) and 189 had a negative blood culture result (non-bacteremic SIRS group). Simultaneously with blood culture, presepsin, procalcitonin (PCT) and C-reactive protein (CRP) were measured. Receiver operating characteristic (ROC) curve analysis was performed for each biomarker as predictor of bacteremia.
Presepsin values were significantly higher in bacteremic SIRS group when compared with non-bacteremic SIRS group. ROC curve analysis and area under curve (AUC) revealed a value of 0.750 for presepsin in differentiating SIRS patients with bacteremia from those without, similar than that for PCT (0.787) and higher than that for CRP (0.602). The best cut-off value for presepsin was 729pg/mL, which was associated with a negative predictive value of 94.4%.
Presepsin may contribute to rule out the diagnosis of bacteremia in SIRS patients admitted to the Emergency Department.
菌血症提示严重细菌感染,死亡率高。其早期诊断对抗菌治疗的实施极为重要,但却是一项诊断挑战。尽管血培养是菌血症诊断的“金标准”,但该方法在血流感染的早期检测中作用有限。在本研究中,我们评估了前降钙素原作为急诊科入院时全身炎症反应综合征(SIRS)患者菌血症预测指标的价值,并将其与现有的感染生物标志物进行比较。
共纳入226例因SIRS入住急诊科的患者。37例患者血培养结果为阳性(菌血症性SIRS组),189例血培养结果为阴性(非菌血症性SIRS组)。在进行血培养的同时,检测前降钙素原、降钙素原(PCT)和C反应蛋白(CRP)。对每个生物标志物作为菌血症预测指标进行受试者操作特征(ROC)曲线分析。
菌血症性SIRS组的前降钙素原水平显著高于非菌血症性SIRS组。ROC曲线分析及曲线下面积(AUC)显示,前降钙素原区分菌血症性SIRS患者和非菌血症性SIRS患者的AUC值为0.750,与PCT(0.787)相似,高于CRP(0.602)。前降钙素原的最佳截断值为729pg/mL,其阴性预测值为94.4%。
前降钙素原可能有助于排除急诊科入院的SIRS患者的菌血症诊断。